ReviewEuropean respiratory review : an official journal of the European Respiratory Society2020
Pulmonary alveolar microlithiasis.
Review in European respiratory review : an official journal of the European Respiratory Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 47 citations in OpenAlex.
- Article
- Pulmonary Alveolar Microlithiasis, a Rare Cause of Progressive Restrictive Lung Disease.Respirology case reports · 2026Article
- A novel homozygous frameshift mutation in exon 13 of SLC34A2 gene causing pulmonary alveolar microlithiasis: A case report.Respiratory medicine case reports · 2026Article
- Article
- Case Report: Novel compound heterozygous mutations inFrontiers in pediatrics · 2026Article
- Article
- Soft tissue calcifications in chronic kidney disease-beyond the vasculature.Pflugers Archiv : European journal of physiology · 2025Review
- Pulmonary alveolar microlithiasis with minimal symptoms and near-complete whiteout on chest imaging.Radiology case reports · 2025Article
- Pulmonary alveolar microlithiasis: A case report and brief review of literature.Caspian journal of internal medicine · 2025Article
- Successful bilateral lung transplantation in pulmonary alveolar microlithiasis: A case report and review of literature.The clinical respiratory journal · 2024Review
- A 20-Year-Old Man With Disproportionate Chest Radiograph Abnormality.CHEST pulmonary · 2024Article
- Pulmonary alveolar microlithiasis combined with gastric mucosal calcification: a case report.Frontiers in medicine · 2024Article
- Exploring the silent storm.Qatar medical journal · 2024Article
- Alveolar Microlithiasis with Mild Clinical Symptoms But Severe Imaging Findings: A Case Report.Clinical medicine insights. Case reports · 2024Article
- Pulmonary alveolar microlithiasis: a rare case report from Syria.Annals of medicine and surgery (2012) · 2023Article
- Two novel gene mutations identified in a child with pulmonary alveolar microlithiasis complicated with bronchitis obliterans: A case report and literature review.Clinical case reports · 2023Article
- The world of rare interstitial lung diseases.European respiratory review : an official journal of the European Respiratory Society · 2023Review
- A Case Report of Pulmonary Alveolar Microlithiasis: Focus on Radiologic Findings.The American journal of case reports · 2023Article
- Losing vigilance in diagnosing pulmonary alveolar microlithiasis: A report on four cases.Journal of clinical imaging science · 2023Article
- Diffuse pulmonary ossification: A case report unveiling clinical and histopathological challenges.Respiratory medicine case reports · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
Abstract
Pulmonary alveolar microlithiasis (PAM) is a fascinating rare lung disease that is associated with the accumulation of hydroxyapatite microliths within the lumen of the alveolar spaces. In most patients, PAM is discovered incidentally on radiographs performed for other purposes, and the typical disease course is characterised by slowly progressive respiratory insufficiency over decades. Recent genetic analyses that have revealed that the deficiency of the sodium-phosphate cotransporter NPT2B is the cause of PAM have enabled the development of powerful animal models that inform our approach to disease management and treatment. Here we review the epidemiology and molecular pathophysiology of PAM, as well as the diagnostic approach, clinical manifestations, radiographic and pathologic features, and clinical management of the disease. Although there are no proven treatments for PAM, progress in our understanding of disease pathogenesis is providing insights that suggest strategies for trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.